AMN · Amn Healthcare Services Inc
$35.76
-0.11 (-0.31%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.33B
Shares
38.73M
Volume · Oct 1
133.04K
Avg daily vol (3M)
705.25K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$35.87
Open$35.45
Day$34.96–36.24
52W close$15.10–36.60
Avg vol 30d592K
Short int3.5M · 9.0% float · 5.9d
Short vol81%
Last earningsAug 6, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 5 wks
filed Aug 7, 2026
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$3.43B
Trailing 12 months
Net income (TTM)
$104.92M
Trailing 12 months
Revenue growth YoY
+2.3%
Year over year
Operating margin
5.8%
Trailing 12 months
P / E (TTM)
13.3
Trailing earnings · reciprocal yield 7.5%
FCF yield
33.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.4%
Year over year · more shares
Price change (1Y)
+85.3%
Trailing year
Short interest
9.0%
Latest settlement · 5.9 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+40%
above
Price vs 50-day avg
+5%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
97%
near high
Momentum
relative strength
1-month return
+7%
trailing
6-month return
+94%
trailing
YTD return
+128%
this year
Relative strength
+82%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $34 › 200d $26 — 50d above 200d
Institutional flow
Accumulating
+14% holders QoQ · +77 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.01% of float · ▲ +2.0% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
287 holders — mid 3-yr range
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
+5%
Y/Y
Gross margin
39%
contracting
EPS growth
+36%
Y/Y
Free cash flow
$233.8M
Valuation
P/E 12.7
below peers
Buyback
$224.4M
remaining
Balance sheet
$733.1M
net debt
Quant / Vol
risk profile
Volatility
67%
annualized · 1-yr
Max drawdown
−29%
past year
ATR
3.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 6, 2026
third quarter
Consolidated revenue
$640M – $655M
prior qtr $673.24M
midpoint −3.8% QoQ
Gross margin
27% – 27.5%
Reported SG&A as a percent of revenue
22% – 22.5%
Operating margin
0.2% – 0.8%
Adjusted EBITDA margin
6.5% – 7%
Nurse and allied segment revenue year-over-year growth
9% – 11%
the third quarter
Consolidated revenue
$640M – $655M
Gross margin
27% – 27.5%
Reported SG&A
22% – 22.5%
Adjusted EBITDA margin
6.5% – 7%
Cash and equivalents at quarter end
at least $225M
Guided vs delivered
· last 6 settled
Consolidated revenue
Third Quarter 2024
guided $660M – $680M
$687.51M
Beat +2.6%
Consolidated revenue
first quarter of 2024
guided $810M – $830M
$820.88M
In line
Consolidated revenue
the fourth quarter
guided $1.13B – $1.15B
$1.36B
Beat +19.6%
Consolidated revenue
fourth quarter
guided $575M – $585M
$2.39B
Beat +312.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+40%
Bullish
Price vs 50-day avg
+5%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
97%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $34 › 200d $26 — 50d above 200d
Institutional flow
Accumulating
+14% holders QoQ · +77 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
9.01% of float · ▲ +2.0% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
287 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $15
Now $36 · 97%
Range high $37
vs 200-day avg +40%
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AMN
this stock
Amn Healthcare Services Inc
|
$1.33B | +127.6% | +4.5% | 12.7 | 9.0% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -8.6% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -11.6% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +28.6% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +14.5% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AMN | +5.8% | +7.0% | +94.0% | +4.6% | +127.6% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +6.5% | +6.8% | +81.8% | +5.2% | +115.8% |
Capital returns
Buyback program
· as of Jun 30, 2026
Authorized
$1.35B
Spent (derived)
$1.13B
Remaining
$224.40M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.